Subjects -> MEDICAL SCIENCES (Total: 8212 journals)
    - ANAESTHESIOLOGY (122 journals)
    - CARDIOVASCULAR DISEASES (334 journals)
    - DENTISTRY (266 journals)
    - ENDOCRINOLOGY (149 journals)
    - FORENSIC SCIENCES (43 journals)
    - HEMATOLOGY (160 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (177 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2241 journals)
    - NURSES AND NURSING (331 journals)
    - OBSTETRICS AND GYNECOLOGY (199 journals)
    - ONCOLOGY (355 journals)
    - OTORHINOLARYNGOLOGY (76 journals)
    - PATHOLOGY (96 journals)
    - PEDIATRICS (254 journals)
    - PSYCHIATRY AND NEUROLOGY (800 journals)
    - RESPIRATORY DISEASES (109 journals)
    - RHEUMATOLOGY (75 journals)
    - SPORTS MEDICINE (77 journals)
    - SURGERY (388 journals)

MEDICAL SCIENCES (2241 journals)            First | 1 2 3 4 5 6 7 8 | Last

Showing 601 - 800 of 3562 Journals sorted alphabetically
F&S Science : Official journal of the American Society for Reproductive Medicine     Open Access  
Facial Plastic Surgery & Aesthetic Medicine     Full-text available via subscription   (Followers: 3)
Facta Universitatis, Series : Medicine and Biology     Open Access  
Family Medicine and Community Health     Open Access   (Followers: 8)
Family Practice     Hybrid Journal   (Followers: 17)
Family Practice & Palliative Care     Open Access   (Followers: 5)
Family Practice Management     Full-text available via subscription   (Followers: 4)
Faridpur Medical College Journal     Open Access  
FEM : Revista de la Fundación Educación Médica     Open Access  
Finlay : Revista de Enfermedades no Transmisibles     Open Access  
Fisioterapia     Full-text available via subscription   (Followers: 2)
Fisioterapia & Saúde Funcional     Open Access  
Flugmedizin · Tropenmedizin · Reisemedizin - FTR     Hybrid Journal  
FMC - Formación Médica Continuada en Atención Primaria     Full-text available via subscription  
Folia Medica     Open Access  
Folia Medica Indonesiana     Open Access  
Folia Morphologica     Full-text available via subscription  
Folia Phoniatrica et Logopaedica     Full-text available via subscription   (Followers: 1)
Fontanus     Open Access  
Food Hydrocolloids for Health     Open Access  
Foodborne Pathogens and Disease     Hybrid Journal   (Followers: 11)
Foot & Ankle Specialist     Hybrid Journal   (Followers: 4)
Foot and Ankle Clinics     Full-text available via subscription   (Followers: 12)
Foot and Ankle Online Journal     Full-text available via subscription   (Followers: 6)
Forensic Science International : Mind and Law     Open Access   (Followers: 4)
Forum Medycyny Rodzinnej     Hybrid Journal  
Forum Zaburzeń Metabolicznych     Hybrid Journal  
Frontières     Full-text available via subscription   (Followers: 3)
Frontiers in Digital Health     Open Access   (Followers: 4)
Frontiers in Medical Technology     Open Access  
Frontiers in Medicine     Open Access   (Followers: 2)
Frontiers in Network Physiology     Open Access   (Followers: 2)
Frontiers in Neuroprosthetics     Open Access   (Followers: 6)
Frontiers in Synaptic Neuroscience     Open Access   (Followers: 2)
Frontiers in Tropical Diseases     Open Access  
Frontiers of Medical and Biological Engineering     Hybrid Journal  
Frontiers of Medicine     Hybrid Journal   (Followers: 2)
Fuss & Sprunggelenk     Hybrid Journal  
Future Medicinal Chemistry     Full-text available via subscription   (Followers: 5)
Future Prescriber     Hybrid Journal  
Future Science OA     Open Access  
Gaceta Médica Boliviana     Open Access  
Gaceta Médica Espirituana     Open Access  
Galen Medical Journal     Open Access  
Galician Medical Journal     Open Access   (Followers: 1)
Galle Medical Journal     Open Access  
Gefäßmedizin Scan     Hybrid Journal  
Gender and the Genome     Open Access   (Followers: 1)
Gene Expression     Full-text available via subscription   (Followers: 1)
General Reanimatology     Open Access  
Genes     Open Access   (Followers: 2)
Genome Instability & Disease     Hybrid Journal  
Geoforum     Hybrid Journal   (Followers: 25)
Gestão e Desenvolvimento     Open Access  
Ghana Medical Journal     Open Access   (Followers: 1)
GigaScience     Open Access   (Followers: 4)
Gimbernat : Revista d’Història de la Medicina i de les Ciències de la Salut     Open Access  
Glia     Hybrid Journal   (Followers: 5)
Global Advances in Health and Medicine     Open Access  
Global Bioethics     Open Access   (Followers: 5)
Global Health : Science and Practice     Open Access   (Followers: 7)
Global Health Journal     Open Access   (Followers: 2)
Global Journal of Integrated Chinese Medicine and Western Medicine     Open Access  
Global Journal of Cancer Therapy     Open Access  
Global Journal of Fertility and Research     Open Access  
Global Journal of Health Science     Open Access   (Followers: 5)
Global Journal of Infectious Diseases and Clinical Research     Open Access  
Global Journal of Medical and Clinical Case Reports     Open Access  
Global Journal of Obesity, Diabetes and Metabolic Syndrome     Open Access   (Followers: 1)
Global Journal of Perioperative Medicine     Open Access  
Global Journal of Rare Diseases     Open Access  
Global Medical & Health Communication     Open Access   (Followers: 1)
Global Reproductive Health     Open Access  
Grande Medical Journal     Open Access  
Growth Factors     Hybrid Journal   (Followers: 2)
GSTF Journal of Advances in Medical Research     Open Access  
Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi     Open Access  
Hamdan Medical Journal     Open Access  
Hämostaseologie     Hybrid Journal   (Followers: 5)
Hämostaseologie     Open Access  
Hand     Hybrid Journal   (Followers: 4)
Hand Clinics     Full-text available via subscription   (Followers: 6)
Hand Therapy     Hybrid Journal   (Followers: 11)
Hard Tissue     Open Access  
Head & Face Medicine     Open Access   (Followers: 1)
Head and Neck Cancer Research     Open Access  
Head and Neck Tumors     Open Access  
Health Information : Jurnal Penelitian     Open Access  
Health Matrix : The Journal of Law-Medicine     Open Access  
Health Notions     Open Access  
Health Science Journal of Indonesia     Open Access  
Health Science Reports     Open Access   (Followers: 1)
Health Sciences and Disease     Open Access   (Followers: 1)
Health Sciences Review     Open Access  
Health Security     Hybrid Journal   (Followers: 1)
Healthcare Technology Letters     Open Access  
Hearing, Balance and Communication     Hybrid Journal   (Followers: 6)
Hearts     Open Access   (Followers: 1)
HEC Forum     Hybrid Journal   (Followers: 1)
Heighpubs Otolaryngology and Rhinology     Open Access  
Heilberufe     Hybrid Journal  
HeilberufeSCIENCE     Hybrid Journal  
Heilpflanzen     Hybrid Journal   (Followers: 5)
Helicobacter     Hybrid Journal  
HemaSphere     Open Access   (Followers: 2)
Hemoglobin     Hybrid Journal  
Hepatology, Medicine and Policy     Open Access  
HERALD of North-Western State Medical University named after I.I. Mechnikov     Open Access  
Herald of the Russian Academy of Sciences     Full-text available via subscription  
Herzschrittmachertherapie + Elektrophysiologie     Hybrid Journal  
Highland Medical Research Journal     Full-text available via subscription  
Hipertensión y Riesgo Vascular     Full-text available via subscription  
HIV Australia     Full-text available via subscription   (Followers: 3)
Homeopathy     Hybrid Journal   (Followers: 1)
Homoeopathic Links     Hybrid Journal  
Hong Kong Physiotherapy Journal     Open Access   (Followers: 14)
Horizonte Medico     Open Access  
Hormones : International Journal of Endocrinology and Metabolism     Hybrid Journal  
Hospital a Domicilio     Open Access  
Hospital Practices and Research     Open Access  
Hospital Topics     Hybrid Journal   (Followers: 1)
Hua Hin Sook Jai Klai Kangwon Journal     Open Access  
Huisarts en wetenschap     Hybrid Journal   (Followers: 4)
Human & Veterinary Medicine - International Journal of the Bioflux Society     Open Access   (Followers: 4)
Human Factors in Healthcare     Open Access  
Human Fertility     Hybrid Journal   (Followers: 4)
Humanidades Médicas     Open Access  
I.P. Pavlov Russian Medical Biological Herald     Open Access  
Iatreia     Open Access  
Ibnosina Journal of Medicine and Biomedical Sciences     Open Access  
IDCases     Open Access  
IEEE Journal of Biomedical and Health Informatics     Hybrid Journal   (Followers: 14)
IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology     Hybrid Journal  
IEEE Journal of Translational Engineering in Health and Medicine     Open Access   (Followers: 5)
IEEE Open Journal of Engineering in Medicine and Biology     Open Access   (Followers: 1)
IEEE Transactions on Medical Robotics and Bionics     Hybrid Journal   (Followers: 3)
IEEE/ACM Transactions on Computational Biology and Bioinformatics     Hybrid Journal   (Followers: 18)
IJID Regions     Open Access   (Followers: 1)
IJS Global Health     Open Access  
IJU Case Reports     Open Access  
iLiver     Open Access   (Followers: 3)
Im OP     Hybrid Journal  
Image Analysis & Stereology     Open Access   (Followers: 1)
IMAGING     Full-text available via subscription   (Followers: 1)
Imaging in Medicine     Open Access  
Imaging Journal of Clinical and Medical Sciences     Open Access   (Followers: 1)
Imam Journal of Applied Sciences     Open Access  
Indian Journal of Ayurveda and lntegrative Medicine Klue     Open Access   (Followers: 3)
Indian Journal of Burns     Open Access   (Followers: 2)
Indian Journal of Clinical Medicine     Open Access  
Indian Journal of Community and Family Medicine     Open Access   (Followers: 2)
Indian Journal of Community Medicine     Open Access   (Followers: 1)
Indian Journal of Health Sciences and Biomedical Research KLEU     Open Access   (Followers: 2)
Indian Journal of Medical Microbiology     Open Access   (Followers: 1)
Indian Journal of Medical Research     Open Access   (Followers: 3)
Indian Journal of Medical Sciences     Open Access   (Followers: 2)
Indian Journal of Medical Specialities     Hybrid Journal  
Indian Journal of Otology     Open Access   (Followers: 1)
Indian Journal of Public Health     Open Access   (Followers: 1)
Indian Journal of Transplantation     Open Access  
Indian Spine Journal     Open Access  
Indo-Pacific Journal of Phenomenology     Open Access   (Followers: 1)
Indonesia Journal of Biomedical Science     Open Access   (Followers: 1)
Indonesian Biomedical Journal     Open Access  
Indonesian Journal for Health Sciences     Open Access   (Followers: 1)
Indonesian Journal of Medicine     Open Access  
Indonesian Journal of Tropical and Infectious Disease     Open Access  
Infant Observation: International Journal of Infant Observation and Its Applications     Hybrid Journal   (Followers: 1)
Inflammation     Hybrid Journal   (Followers: 3)
Inflammation Research     Hybrid Journal   (Followers: 4)
Info Diabetologie     Full-text available via subscription   (Followers: 1)
Infodir : Revista de Información científica para la Dirección en Salud     Open Access  
Informatics in Medicine Unlocked     Open Access  
Injury Prevention     Hybrid Journal   (Followers: 6)
InnovAiT     Hybrid Journal   (Followers: 1)
Innovare Journal of Health Science     Open Access  
Innovare Journal of Medical Science     Open Access  
Innovation in Aging     Open Access   (Followers: 1)
Inside Precision Medicine     Full-text available via subscription   (Followers: 4)
Insights in Biology and Medicine     Open Access  
Integrative and Complementary Therapies     Full-text available via subscription   (Followers: 4)
Integrative Medicine Insights     Open Access   (Followers: 1)
Integrative Medicine International     Open Access   (Followers: 1)
Integrative Medicine Research     Open Access   (Followers: 3)
Intellectual Disability Australasia     Full-text available via subscription   (Followers: 12)
Intelligence-Based Medicine     Open Access  
Intelligent Medicine     Open Access   (Followers: 1)
intensiv     Hybrid Journal   (Followers: 1)
interactive Journal of Medical Research     Open Access  
Interdisciplinary Perspectives on Infectious Diseases     Open Access  
Interdisciplinary Sciences : Computational Life Sciences     Hybrid Journal   (Followers: 2)
Internal Medicine     Open Access   (Followers: 1)
International Biomechanics     Open Access   (Followers: 1)
International Health     Hybrid Journal   (Followers: 5)
International Health Trends and Perspectives     Open Access  
International Journal for Numerical Methods in Biomedical Engineering     Hybrid Journal   (Followers: 2)
International Journal for Vitamin and Nutrition Research     Hybrid Journal   (Followers: 10)
International Journal of Academic Medicine     Open Access   (Followers: 1)
International Journal of Advance in Medical Science     Open Access  
International Journal of Advanced Medical and Health Research     Open Access  

  First | 1 2 3 4 5 6 7 8 | Last

Similar Journals
Journal Cover
Global Journal of Cancer Therapy
Number of Followers: 0  

  This is an Open Access Journal Open Access journal
ISSN (Online) 2581-5407
Published by Peertechz Homepage  [75 journals]
  • Clinical trials cannot provide sufficient accuracy for studying weak
           factors necessary for curing chronic diseases

    • Abstract: Chronic diseases are still known as incurable diseases, and we suspect that the medical research model is unfit for characterizing chronic diseases. In this study, we examined accuracy and reliability required for characterizing chronic diseases, reviewed implied presumptions in clinical trials and assumptions used in statistical analysis, examined sources of variances normally encountered in clinical trials, and conducted numeric simulations by using hypothetical data for several theoretical and hypothetical models. We found that the sources of variances attributable to personal differences in clinical trials can distort hypothesis test outcomes, that clinical trials introduce too many errors and too many inaccuracies that tend to hide weak and slow-delivering effects of treatments, and that the means of treatments used in statistical analysis have little or no relevance to specific patients. We further found that a large number of uncontrolled co-causal or interfering factors normally seen in human beings can greatly enlarge the means and the variances or experimental errors, and the use of high rejection criteria (e.g., small p values) further raises the chances of failing to find treatment effects. As a whole, we concluded that the research model using clinical trials is wrong on multiple grounds under any of our realistic theoretical and hypothetical models, and that misuse of statistical analysis is most probably responsible for failure to identify treatment effects for chronic diseases and failure to detect harmful effects of toxic substances in the environment. We proposed alternative experimental models involving the use of single-person or mini optimization trials for studying low-risk weak treatments.
      PubDate: 23 Mar, 2022
  • Surgery, Chemotherapy and Radiotherapy May Promote Cancer Growth Speeds
           and Shorten Patient Lives

    • Abstract: Medicine fails to find predictable cures for cancer in more than a century, and we explored the feasibility of controlling cancer growth speed by using lifestyle factors. After conducting an extensive literature review, we conducted simulations for cancer growth courses to see the feasibility of controlling cancer growth speeds.We found that (1) medical treatments are often accompanied by three to four lethal factors: treatment side-effects, emotional distress, and chronic stress, reduced exercises and physical inactivity, and excessive nutrition in some cases; (2) clinical trial exaggerates treatments short-term benefits and underestimates the slow-delivering adverse side effects as a result of statistical averaging, interfering effects of personal lifestyle factors and insufficient follow-up times; (3) the benefits of medical treatments are limited by chain comparisons, where surgery may work as a negative standard relative to the best alternatives for resolving cancer; (4) the strategy of destroying the tumor or killing all cancer cells is unworkable; (5) medical treatments can turn natural cancer growth curve into approximately doubly exponential curve; (6) multiple-factor non-medical measures are potentially much more powerful than medical treatments in controlling cancer growth and metastasis speeds; and (7) cancer early diagnosis and over treatments are unwise strategies in light of discoveries. Based on huge increases in cancer growth rate constants, substantial loss of vital organ functional capacity, and severe systemic aging-like cellular damages, we concluded that medical treatments may promote cancer growth and metastasis speeds and shorten patient lives in most situations, and the claimed benefits are caused by triple biases of clinical trials. By using the same method to explore how several lifestyle factors affect cancer growth rates, we concluded that the better strategy for ending the global cancer epidemic in the future is changing caner treatment strategy from killing cancer cells to slowing down cancer growth rates by using various lifestyle factors in combination. This study in part explains why cancer can self-resolve.
      PubDate: 19 Mar, 2022
  • Essentially new inhibitors of metastasis of malignant tumors for
           chemotherapy-sparing treatment

    • Abstract: The purpose of this work was1. Processing a new concept of specific inhibitors for metastasis to mercy cancer chemotherapy for oncology.2. A chemical synthesis of Multinucleated Anion active Metastasis inhibitors based on processed conception.3. Trial them in D60p4 cell line culture of atypical fibroblasts of different concentrations.Georgia has received a patent for the first medicine (Amphicezine) of this class, which does not damage the normal healthy cells in the body. There are presented the synthesis schemes and methods of prospective metastasis inhibitors by the authors. The second-generation works of Multinucleated Anion active Metastasis inhibitors have been completed, there is also discussed and shown multifunctional action on tumor cells, connections between oncodrugs activity and their ligand properties.
      PubDate: 24 Feb, 2021
  • Patient’s experiences on receiving radiation therapy for head and neck
           cancer pre, pending and post treatment: A qualitative study at Bugando
           medical centre Mwanza, Tanzania

    • Abstract: The objective of this study was to present a descriptive summary of patients experiences on receiving radiation treatment for Head And Neck Cancers (HNC). A qualitative descriptive study design was used and 60 patients who undergo radiation therapy for head and neck cancers at Bugando medical centre in Mwanza were randomly selected. The face to face interviews were conducted for data collection to 60 patients who receive radiation treatment for head and neck cancers between April 2021 to June 2021 for descriptive and thematic analysis of data collected. Experiences from interview revealed six main themes: Understanding and acceptance of disease, Desire to know the treatment plan and the overall treatment process,Functional disability, Change of body image, Decrease of social interactions, Fear of cancer recurrence. Little attention have been directed in knowing the experiences on receiving radiation treatment by patients. Findings from this study have contributed to the development of head and neck cancer patients support and education to patients and families.
      PubDate: 23 Aug, 2021
  • Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint
           blockades in Immuno-Oncology

    • Abstract: Cancer biology clinical breakthroughs in this millennium requires the development of new methods and techniques to suit the challenge of the global health menace. Immunotherapy is a technique that has engendered advancement in cancer studies. Immuno-oncology aims at the recognition of tumour antigens and elimination of tumour cells. In this paper, the pathogenesis of carcinogenesis and role of immunosurveillance in tumour prevention is critically analyzed. The paper also attempts to show the role of MHC-I and IFN signaling, the concerted effort of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4), Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1), and metabolic alteration in immune evasion mechanism of cancerous cells. The use of Immune Checkpoint Inhibitors (ICPIs) in combination with anti-CTLA-4 and anti-PD-1 antibodies has increased survival in some cancers and shows promise in others. When these agents are administered, however, there are toxicities known as “Immune-related adverse events.” A brief overview on the dermatologic toxicity, endocrinopathy, hepatotoxicity and diarrhoea/enterocolitis is discussed. This paper concludes by mentioning the promising potential of genomic sequencing technology in cancer immunotherapy.
      PubDate: 19 May, 2021
  • Evaluation of changes in tumor volume following upfront chemotherapy for
           locally advanced Non Small Cell Lung Cancer (NSCLC)

    • Abstract: Objective: In the setting of upfront chemotherapy, some degree of reduction in primary tumor volume may occur. This may be of critical importance in the setting of locally advanced Non Small Cell Lung Cancer (NSCLC) when upfront definitive irradiation is not feasible due to critical organ dose constraints. Selected patients with tumor volume reduction after upfront systemic therapy may be considered for curative radiation therapy (RT). To address this issue, we evaluated changes in tumor volume following upfront chemotherapy for NSCLC in this original article.Materials and methods: Patients receiving upfront chemotherapy for locally advanced NSCLC were identified and analyzed. All patients had upfront chemotherapy and were subsequently referred for curative RT at Department of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences. Tumor size changes following upfront chemotherapy have been documented for performing the comparative evaluation. Results: Decision making for individualized management of patients was based on thorough multidisciplinary evaluation with input from experts in pulmonology, pulmonary surgery, radiology, medical oncology, and radiation oncology. Tumor size changes were assessed in a series of patients receiving upfront chemotherapy for NSCLC. There was a mean decrease of 24% in tumor volume following upfront chemotherapy. Conclusion: A mean decrease of 24% in tumor volume occurred following upfront chemotherapy in our study for patients with locally advanced NSCLC having extensive tumor burden. Adaptation of curative RT target volumes with respect to tumor volume reductions should be assessed in prospective randomized studies to shed light on the issue of reduced volume irradiation.
      PubDate: 15 Mar, 2021
  • Disease biology alters the response to frontline bortezomib, lenalidomide
           and dexamethasone in Multiple Myeloma

    • Abstract: Background: Achievement of the best initial response to induction regimen in multiple myeloma is a prognostic factor for disease outcome. The triplet regimen-bortezomib, lenalidomide, and dexamethasone, VRd, is the preferred induction regimen in newly diagnosed Multiple Myeloma (MM) due to its favorable impact on overall survival. However, recent studies showed a deeper response and superior progression-free survival with quadruplet regimen, daratumumab-VRd, when compared to VRd. Yet, the quadruplet regimen also comes with additional toxicities. Balancing efficacy and toxicity in selecting an induction regimen is a challenge due to advanced age and comorbidities in the multiple myeloma population.The purpose of this study is to identify biological markers that could potentially affect the response rate to upfront VRd.Patients and methods: For this cross-sectional study, we included patients with MM treated with frontline VRd starting April 2011 through May 2018. We analyzed the correlation between patient demographics, disease biology, disease burden and stage at diagnosis, and response to therapy.Results: After four cycles of VRd, we analyzed the response rate on 120 subjects. The overall response rates to VRd were 50% of patients achieved Very Good Partial Response (VGPR) or better, 43% achieved Partial Response (PR), 5% did not respond to treatment. We showed a statistically significant difference in treatment outcomes between myeloma subtypes particularly involved immunoglobulin, IgA, and IgG myeloma. We report an increased incidence of VGPR or better in IgA myeloma (79%) as compared to IgG myeloma (37%) (P-Value < 0.0006).Conclusion: We conclude that IgG subtype multiple myeloma is associated with a suboptimal response to frontline VRd.
      PubDate: 13 Feb, 2021
  • Application of nano based drug delivery channel against leukemia
           chemotherapeutic resistance

    • Abstract: To the management of leukemia, traditional chemotherapy is characterized by repeated dosage, adverse side effects, disruption to the immune system and other organs with rapidly proliferating cells due to non-specific targeting, insolubility, and failure to attack the tumor center, low survival treatment impairments, and resistance from the targeted cancerous cells. The management of most anti-leukemic drugs would be improved if, through a suitable scientific process that can be released to their biological targets through technological manipulation at the nano-molecular dimension. Nanoparticles are increasingly being implemented and adopted in alleviating numerous constraints with the conventional technique for drug delivery with cancer therapy. With excessive drug localization and cell adhesion, nanotechnology has presented an opportunity to selectively secure easy links to cancerous cells as it is feasible to program nanoparticles such as gold to identify cancerous cells as well as provide selective and precise drug delivery mechanisms that prevent interplay with normal cells. This review outlook essentially illustrates the significance of nano-based anticancer therapy for active targeting, the drawbacks of traditional chemotherapy, the responsive pH existence of nano-based anticancer drugs with cellular delivery through a stabilized biocompatible carrier, the biochemical compositions of nano-structured media, existing methodologies for nano-based anticancer therapy (leukemia) formulation and recognition of gold nanoparticles as an ideal anticancer drug delivery material.
      PubDate: 09 Feb, 2021
  • Assessment of the role of multimodality imaging for treatment volume
           definition of intracranial ependymal tumors: An original article

    • Abstract: Objective: Radiotherapy (RT) can be used for primary treatment, adjuvant therapy, or for salvage of recurrences of intracranial ependymal tumors. In recent years, there is a rising trend towards reducing the adverse effects of RT by incorporation of modernized techniques. Accurate and precise RT treatment volume is essential for optimization of treatment results. Herein, we evaluated irradiation target designation of intracranial ependymal tumors.Materials and methods: In this study, irradiation target designation was assessed for intracranial ependymal tumors. RT target volume definition was evaluated with comparative analysis for patients receiving irradiation for intracranial ependymal tumors.Results: Optimal target coverage and minimal exposure of normal tissues was prioritized in RT treatment planning. Ground truth target volume determination was done with meticulous assessment of physicians. As the primary result, it was found that the ground truth target voume was identical with target determination with Computed Tomography (CT)-Magnetic Resonance Imaging (MRI) fusion based planning. Conclusion: Incorporation of MRI in target definition process should be suggested for improving accuracy and precision of target and treatment volume definition for successful radiotherapeutic management of intracranial ependymal tumors despite the need for further supporting evidence.
      PubDate: 06 Jul, 2021
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762

Your IP address:
Home (Search)
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-